AMGN - Company ID 0000318154
AMGEN INC (AMGN) reported revenue of $36.75B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $36.75B | +10.0% |
| FY 2024 | $33.42B | +18.6% |
| FY 2023 | $28.19B | +7.1% |
| FY 2022 | $26.32B | +1.3% |
| FY 2021 | $25.98B | +2.2% |
| FY 2020 | $25.42B | +8.8% |
| FY 2019 | $23.36B | -1.6% |
| FY 2018 | $23.75B | +3.9% |
| FY 2017 |
AMGEN INC (AMGN) reported revenue of $36.75B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, AMGEN INC's revenue grew from $15.58B to $36.75B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $22.85B |
| -0.6% |
| FY 2016 | $22.99B | +6.1% |
| FY 2015 | $21.66B | +8.0% |
| FY 2014 | $20.06B | +7.4% |
| FY 2013 | $18.68B | +8.2% |
| FY 2012 | $17.27B | +10.8% |
| FY 2011 | $15.58B | - |